17 Participants and Exposure Adults 18 years and older with T2D taking semaglutide (GLP-1RA), dulaglutide (GLP-1RA), exenatide (GLP-1RA), empagliflozin (sodium-glucose cotransporter 2 [SGLT2] inhibitor), sitagliptin (dipeptidyl peptidase 4 [DPP4] inhibitor), or glipizide (sulfonylurea) during the study period (December 1, 2017-December 31, 2023) were included
By restoring optimal B12 levels, these injections help support metabolism , enhance mental clarity and mood , and promote sustained energy throughout the day
For DPP-4 inhibitors the IRRs were likewise lower in both periods, compared to the pretreatment period (Fig
Mutually exclusive HCRU endpoints included inpatient hospitalizations, emergency room (ER) visits, and outpatient medical services (including physician office visits, and other outpatient services)
They target the underlying causes of tired eyes